Correlation between pathologic complete response (pCR), event-free survival (EFS)/disease-free survival (DFS) and overall survival (OS) in neoadjuvant and/or adjuvant (NAdj/Adj) hormone receptor positive (HR plus ) and human epidermal growth factor receptor-2 negative (HER2-) breast cancer (BC)